User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure

Primary tabs

Wittebole, Xavier [UCL] Hantson, Philippe [UCL]

INTRODUCTION: There is an increasing interest in recent developments in bioartificial and non-bioartificial devices, so called extracorporeal liver assist devices, which are now used widely not only to increase drug elimination, but also to enhance the removal of endogenous substances in acute liver failure. Most of the non-bioartificial techniques are based on the principle of albumin dialysis. The objective is to remove albumin-bound substances that could play a role in the pathophysiology of acute liver failure by dialysing blood against an albumin-containing solution across a high flux permeable membrane. The most widely used device is the Molecular Adsorbent Recirculating System (MARS™). METHODS: The relevant English and French literature was identified through Medline using the terms, 'molecular adsorbent recirculating system', 'MARS', 'acute liver failure', 'acute poisoning', 'intoxication'. This search identified 139 papers of which 48 reported on a toxic cause for the use of MARS™. Of these 48 papers, 39 specified the substance (eighteen different substances were identified); two papers reported on the same group of patients. BIOARTIFICIAL AND NON-BIOARTIFICIAL SYSTEMS: Bioartificial systems based on porcine hepatocytes incorporated in the extracorporeal circuit are no longer in use due to the possibility of porcine retroviral transmission to humans. Historically, experience with such devices was limited to a few cases of paracetamol poisoning. In contrast, an abundant literature exists for the non-bioartificial systems based on albumin dialysis. The MARS™ has been used more widely than other techniques, such as the one using fractionated plasma separation and adsorption (Prometheus™). All the extracorporeal liver assist devices are able to some extent to remove biological substances (ammonia, urea, creatinine, bilirubin, bile acids, amino acids, cytokines, vasoactive agents) but the real impact on the patient's clinical course has still to be determined. Improvement in cardiovascular or neurological dysfunction has been shown both in acute liver failure and acute-on-chronic liver failure but no impact on mortality has been reported. ACUTE POISONING WITH LIVER FAILURE: Randomized controlled trials are very limited in number and patients poisoned by paracetamol or Amanita phalloides are usually included for outcome analysis in larger groups of acute liver failure patients. Initial results look promising but should be confirmed. Beyond its effect in liver failure, MARS™ could also enhance the elimination of the drug or toxin responsible for the failure, as is described with paracetamol. ACUTE POISONING WITHOUT LIVER FAILURE: Extracorporeal liver assist devices have also been used to promote elimination of drugs that are highly protein bound. Data in various case reports confirm a high elimination of phenytoin, theophylline and diltiazem. However, definite conclusions on the toxicokinetic or clinical efficacy cannot be drawn. CONCLUSIONS: Despite the lack of large multicentre randomized trials on the use of MARS™ in patients with acute liver failure, the literature shows clinical and biological benefit from this technique. In drug or toxin-induced acute liver failure, such as paracetamol or mushroom poisoning, MARS™ has been used extensively, confirming in a non-randomized fashion, the positive effect observed in the larger population of acute liver failure patients. Furthermore, as MARS™ has been shown in experimental studies to remove protein-bound substances, it is potentially a promising treatment for patients with acute poisoning from drugs that have high protein-binding capacity and are metabolized by the liver, especially, if they develop liver failure concomitantly.

Document type Article de périodique (Journal article) – Synthèse de littérature – Journal Article, Review
Access type Accès restreint
Publication date 2011
Language Anglais
Journal information "Clinical Toxicology" - Vol. 49, no. 9, p. 782-793 (2011)
Peer reviewed yes
Publisher Informa Healthcare ((United States) New York)
issn 1556-3650
e-issn 1556-9519
Publication status Publié
Affiliations UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology
UCL - SSS/IREC/MEDA - Pôle de médecine aiguë
UCL - (SLuc) Service de soins intensifs
MESH Subject Acetaminophen - toxicity ; Acute Disease ; Metals, Heavy - poisoning, toxicity ; Mushroom Poisoning - therapy ; Phenytoin - adverse effects ; Poisoning - complications, therapy ; Sorption Detoxification - instrumentation, methods ; Triazines - adverse effects ; Albumins - metabolism ; Amanita - chemistry ; Amphetamine - poisoning ; Calcium Channel Blockers - adverse effects ; Cocaine - poisoning ; Humans ; Liver Failure - therapy ; Liver, Artificial
Links
  1. Bernuau Jacques, Rueff Bernard, Benhamou Jean-Pierre, Fulminant and Subfulminant Liver Failure: Definitions and Causes, 10.1055/s-2008-1040593
  2. O’Grady JG, Gastroenterology, 97, 439 (1989)
  3. Mitzner SR, Ann Hepatol, 10, S21 (2011)
  4. Pitkin Zorina, Mullon Claudy, Evidence of Absence of Porcine Endogenous Retrovirus (PERV) Infection in Patients Treated with a Bioartificial Liver Support System, 10.1046/j.1525-1594.1999.06444.x
  5. MITZNER S, STANGE J, KLAMMT S, RISLER T, ERLEY C, BADER B, BERGER E, LAUCHART W, PESZYNSKI P, FREYTAG J, Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial, 10.1053/lv.2000.6355
  6. Heemann U, Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study, 10.1053/jhep.2002.36130
  7. Sen Sambit, Mookerjee Rajeshwar P., Cheshire Lisa M., Davies Nathan A., Williams Roger, Jalan Rajiv, Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis, 10.1016/j.jhep.2005.01.032
  8. Schmidt L, Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure, 10.1053/jlts.2001.26059
  9. LALEMAN W., WILMER A., EVENEPOEL P., VERSLYPE C., FEVERY J., NEVENS F., Review article: non-biological liver support in liver failure, 10.1111/j.1365-2036.2006.02765.x
  10. Kantola Taru, Koivusalo Anna-Maria, Höckerstedt Krister, Isoniemi Helena, The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients*, 10.1111/j.1432-2277.2008.00698.x
  11. Saliba F., Camus C., Durand F., Mathurin P., Delafosse B., Barange K., Perrigault P.F., Belnard M., Letierce A., Ichai P., Samuel D., CO.88 Étude prospective, randomisée, multicentrique, évaluant l’efficacité et la tolérance du système de dialyse hépatique à l’albumine MARS® chez les patients atteints d’une hépatite fulminante en attente de transplantation, 10.1016/s0399-8320(09)72884-2
  12. Schmidt L, Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial, 10.1053/jlts.2003.50051
  13. Abraham R.Ben, Szold O, Merhav H, Biderman P, Kidron A, Nakache R, Oren R, Sorkine P, Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients, 10.1016/s0041-1345(01)02241-2
  14. Record C. O., Buxton B., Chase R. A., Curzon G., Murray-Lyon I. M., Williams R., Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy, 10.1111/j.1365-2362.1976.tb00533.x
  15. Fischer JE, Surgery, 78, 279 (1975)
  16. Awad Samir S., Swaniker Fresca, Magee John, Punch Jeffrey, Bartlett Robert H., Results of a phase I trial evaluating a liver support device utilizing albumin dialysis, 10.1067/msy.2001.116671
  17. Loock J, Mitzner SR, Peters E, Schmidt R, Stange J., Loock J., Mitzner S. R., Peters E., Schmidt R., Stange J., Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS), 10.1034/j.1600-0676.2002.00006.x
  18. Schmidt L. E., Tofteng F., Strauss G. I., Larsen F. S., Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy, 10.1080/00365520410003227
  19. Koivusalo Anna-Maria, Teikari Taru, Höckerstedt Krister, Isoniemi Helena, Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy, 10.1007/s11011-008-9110-9
  20. Mitzner SR, J Am Soc Nephrol, 12, S75 (2001)
  21. Mitzner Steffen R., Stange Jan, Klammt Sebastian, Peszynski Piotr, Schmidt Reinhard, Albumin dialysis using the molecular adsorbent recirculating system : , 10.1097/00041552-200111000-00008
  22. Guo Li-Min, Liu Jing-Yuan, Xu Dao-Zhen, Li Bao-Shun, Han Hao, Wang Ling-Hang, Zhang Wei-Yan, Lu Lian-He, Guo Xia, Sun Feng-Xia, Zhang Hong-Yu, Liu Xiao-Dong, Zhang Jian-Ping, Yao Yun, He Zhong-Ping, Wang Min-Min, Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome : Application of MARS to remove NO and cytokines in severe liver failure patients, 10.1034/j.1478-3231.23.s.3.7.x
  23. Sen Sambit, Davies Nathan A., Mookerjee Rajeshwar P., Cheshire Lisa M., Hodges Stephen J., Williams Roger, Jalan Rajiv, Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study, 10.1002/lt.20236
  24. Di Campli C., Zocco M.A., Gaspari R., Novi M., Candelli M., Santoliquido A., Flore R., Tondi P., Proietti R., Gasbarrini G., Pola P., Gasbarrini A., The Decrease in Cytokine Concentration During Albumin Dialysis Correlates With the Prognosis of Patients With Acute on Chronic Liver Failure, 10.1016/j.transproceed.2005.06.040
  25. Auth Marcus KH., Kim Hyun Soo, Beste Mechthild, Bonzel Klaus E., Baumann Ulrich, Ballauff Antje, Wallot Michael, Borchers Tanja, Vester Udo, Grasemann Corinna, Hauffa Berthold, Hoyer Peter F., Gerken Guido, Voit Thomas, Removal of Metabolites, Cytokines and Hepatic Growth Factors by Extracorporeal Liver Support in Children : , 10.1097/00005176-200501000-00010
  26. Novelli G., Annesini M.C., Morabito V., Cinti P., Pugliese F., Novelli S., Piemonte V., Turchetti L., Rossi M., Berloco P.B., Cytokine Level Modifications: Molecular Adsorbent Recirculating System Versus Standard Medical Therapy, 10.1016/j.transproceed.2009.03.035
  27. Isoniemi H., Koivusalo A.-M., Repo H., Ilonen I., Höckerstedt K., The Effect of Albumin Dialysis on Cytokine Levels in Acute Liver Failure and Need for Liver Transplantation, 10.1016/j.transproceed.2004.11.060
  28. Falkenhagen Dieter, Strobl Wolfram, Vogt Gerd, Schrefl Andreas, Linsberger Ingrid, Gerner Franz Joseph, Schoenhofen Michael, Fractionated Plasma Separation and Adsorption System: A Novel System for Blood Purification to Remove Albumin Bound Substances, 10.1046/j.1525-1594.1999.06292.x
  29. Evenepoel Pieter, Laleman Wim, Wilmer Alexander, Claes Kathleen, Kuypers Dirk, Bammens Bert, Nevens Frederik, Vanrenterghem Yves, Prometheus Versus Molecular Adsorbents Recirculating System: Comparison of Efficiency in Two Different Liver Detoxification Devices, 10.1111/j.1525-1594.2006.00215.x
  30. Rifai K, World J Gastroenterol, 12, 940 (2006)
  31. Peszynski P, Stange J, Mitzner S, Klammt S, Majcher-Peszynska J, Wacke R, Drewelow B, Schmidt R, Removal of Benzodiazepine-like Substances as a Cause of Improvement of Hepatic Encephalopathy during Albumin Dialysis, 10.1055/s-2001-919049
  32. Sen Sambit, Ytreb� Lars M., Rose Christopher, Fuskevaag Ole-Martin, Davies Nathan A., Nedredal Geir I., Williams Roger, Revhaug Arthur, Jalan Rajiv, Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs, 10.1007/s00134-003-2141-0
  33. Pugliese F., Novelli G., Poli L., Levi Sandri G.B., Di Folco G., Ferretti S., Morabito V., Ruberto F., Berloco P.B., Hemodynamic Improvement as an Additional Parameter to Evaluate the Safety and Tolerability of the Molecular Adsorbent Recirculating System in Liver Failure Patients, 10.1016/j.transproceed.2008.05.077
  34. Lai Wai Kwan, Haydon Geoff, Mutimer David, Murphy Nick, The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure, 10.1007/s00134-005-2786-y
  35. Sen Sambit, Rose Christopher, Ytrebø Lars M., Davies Nathan A., Nedredal Geir I., Drevland Synnøve S., Kjønnø Marianne, Prinzen Frits W., Hodges Stephen J., Deutz Nicolaas E. P., Williams Roger, Butterworth Roger F., Revhaug Arthur, Jalan Rajiv, Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: A randomized study* : , 10.1097/01.ccm.0000196203.39832.3c
  36. Sorkine Patrick, Ben Abraham Ron, Szold Oded, Biderman Philippe, Kidron Anat, Merchav Hadar, Brill Shlomo, Oren Ran, Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure : , 10.1097/00003246-200107000-00006
  37. Siewert-Delle A, Henriksson B-Å, Bäckman L, Albumin dialysis with the M.A.R.S. (Molecular Absorbent Recirculating System) for a patient with acute liver failure due to paracetamol intoxication: A case-report, 10.1055/s-2001-919041
  38. Pugliese F., Ruberto F., Perrella S.M., Cappannoli A., Bruno K., Martelli S., Celli P., Summonti D., D’Alio A., Tosi A., Novelli G., Morabito V., Poli L., Rossi M., Berloco P.B., Pietropaoli P., Modifications of Intracranial Pressure After Molecular Adsorbent Recirculating System Treatment in Patients With Acute Liver Failure: Case Reports, 10.1016/j.transproceed.2007.05.061
  39. Novelli Gilnardo, Rossi Massimo, Pretagostini Renzo, Novelli Luigi, Poli Luca, Ferretti Giancarlo, Iappelli Massimo, Berloco Pasquale, Cortesini Raffaello, A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion : A 3-year experience with MARS, 10.1034/j.1478-3231.23.s.3.4.x
  40. Novelli G., Rossi M., Pretagostini M., Pugliese F., Ruberto F., Novelli L., Nudo F., Bussotti A., Corradini S., Martelli S., Berloco P.B., One Hundred Sixteen Cases of Acute Liver Failure Treated With MARS, 10.1016/j.transproceed.2005.07.015
  41. Sussman Norman L., Chong Maria G., Koussayer Tarek, He Da-Er, Shang Thomas A., Whisennand Hartwell H., Kelly James H., Reversal of fulminant hepatic failure using an extracorporeal liver assist device, 10.1002/hep.1840160112
  42. Ellis A J, Hughes R D, Wendon J A, Dunne J, Langley P G, Kelly J H, Gislason G T, Sussman N L, Williams R, Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure, 10.1002/hep.510240625
  43. Demetriou Achilles A., Brown Robert S., Busuttil Ronald W., Fair Jeffrey, McGuire Brendan M., Rosenthal Philip, Am Esch Jan Schulte, Lerut Jan, Nyberg Scott L., Salizzoni Mauro, Fagan Elizabeth A., de Hemptinne Bernard, Broelsch Christoph E., Muraca Maurizio, Salmeron Joan Manuel, Rabkin John M., Metselaar Herold J., Pratt Daniel, De La Mata Manuel, McChesney Lawrence P., Everson Gregory T., Lavin Philip T., Stevens Anthony C., Pitkin Zorina, Solomon Barry A., Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure : , 10.1097/01.sla.0000124298.74199.e5
  44. McIntyre C. W., Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication, 10.1093/ndt/17.2.316
  45. Banares Cazinares R, Rev Esp Enferm Dig, 95, 876 (2003)
  46. Felldin M, Friman S, Backman L, Siewert-Delle A, Henriksson B.-Å, Larsson B, Olausson M, Treatment with the molecular adsorbent recirculating system in patients with acute liver failure, 10.1016/s0041-1345(03)00086-1
  47. Koivusalo A.-M., Yildirim Y., Vakkuri A., Lindgren L., Hockerstedt K., Isoniemi H., Experience with albumin dialysis in five patients with severe overdoses of paracetamol, 10.1034/j.1399-6576.2003.00190.x
  48. Hydzik P, Przegl Lek, 61, 377 (2004)
  49. Lubezky N, Isr Med Assoc J, 6, 467 (2004)
  50. Zhou XM, Artif Organs, 28, 483 (2004)
  51. Camus Christophe, Lavoué Sylvain, Gacouin Arnaud, Le Tulzo Yves, Lorho Richard, Boudjéma Karim, Jacquelinet Christian, Thomas Rémi, Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation, 10.1007/s00134-006-0340-1
  52. Kantola Taru, Koivusalo Anna-Maria, Höckerstedt Krister, Isoniemi Helena, The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients*, 10.1111/j.1432-2277.2008.00698.x
  53. Novelli G., Rossi M., Morabito V., Pugliese F., Ruberto F., Perrella S.M., Novelli S., Spoletini G., Ferretti G., Mennini G., Berloco P.B., Pediatric Acute Liver Failure With Molecular Adsorbent Recirculating System Treatment, 10.1016/j.transproceed.2008.05.075
  54. Camus Christophe, Lavoué Sylvain, Gacouin Arnaud, Compagnon Philippe, Boudjéma Karim, Jacquelinet Christian, Thomas Rémi, Le Tulzo Yves, Liver Transplantation Avoided in Patients With Fulminant Hepatic Failure Who Received Albumin Dialysis With the Molecular Adsorbent Recirculating System While on the Waiting List: Impact of the Duration of Therapy, 10.1111/j.1744-9987.2009.00708.x
  55. Kantola Taru, Survival predictors in patients treated with a molecular adsorbent recirculating system, 10.3748/wjg.15.3015
  56. Koivusalo Anna-Maria, Kantola Taru, Arola Johanna, Höckerstedt Krister, Kairaluoma Pekka, Isoniemi Helena, Is It Possible to Gain Extra Waiting Time to Liver Transplantation in Acute Liver Failure Patients Using Albumin Dialysis?, 10.1111/j.1744-9987.2009.00753.x
  57. de Geus Hilde, Mathôt Ron, van der Hoven Ben, Tjoa Mila, Bakker Jan, Enhanced Paracetamol Clearance with Molecular Adsorbents Recirculating System (MARS®) in Severe Autointoxication, 10.1159/000319955
  58. Kantola T., Ilmakunnas M., Koivusalo A.-M., Isoniemi H., Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland, 10.1177/145749691110000103
  59. Skwarek A., Grodzicki M., Nyckowski P., Kotulski M., Zieniewicz K., Michalowicz B., Patkowski W., Grzelak I., Paczkowska A., Giercuszkiewicz D., Sańko-Resmer J., Pączek L., Krawczyk M., The Use Prometheus FPSA System in the Treatment of Acute Liver Failure: Preliminary Results, 10.1016/j.transproceed.2005.12.011
  60. Karvellas CJ, Int J Artif Organs, 31, 450 (2008)
  61. Karvellas Constantine J., Bagshaw Sean M., McDermid Robert C., Stollery Daniel E., Bain Vincent G., Gibney R.T. Noel, A Case-Control Study of Single-Pass Albumin Dialysis for Acetaminophen-Induced Acute Liver Failure, 10.1159/000227280
  62. Faulstich H., MUSHROOM POISONING, 10.1016/s0140-6736(80)90400-6
  63. WIELAND THEODOR, The toxic peptides from Amanita mushrooms, 10.1111/j.1399-3011.1983.tb02093.x
  64. Leist M, Gantner F, Naumann H, Bluethmann H, Vogt K, Brigelius-Flohe R, Nicotera P, Volk HD, Wendel A, Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins, 10.1053/gast.1997.v112.pm9041255
  65. Jaeger Albert, Jehl FranÇOis, Flesch FranÇOise, Sauder Philippe, Kopferschmitt Jacques, Kinetics of amatoxins in human poisoning: Therapeutic implications, 10.3109/15563659309000374
  66. Von Clarmann M, Fortschr Med, 97, 1999 (1979)
  67. Jander S., Bischoff J., Woodcock B.G., Plasmapheresis in the Treatment of Amanita Phalloides Poisoning: II. A Review and Recommendations, 10.1046/j.1526-0968.2000.004004308.x
  68. Shi Y, He J, Chen S, Zhang L, Yang X, Wang Z, Wang M., Shi Yufei, He Jianglong, Chen Shibin, Zhang Lunli, Yang Xiaolan, Wang Zhihua, Wang Minmin, MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning - a case report, 10.1034/j.1600-0676.2002.00017.x
  69. Catalina M.V., Núñez O., Ponferrada A., Menchén L., Matilla A., Clemente G., Bañares R., Toxicidad hepática por ingesta de setas: curso clínico y nuevas perspectivas de tratamiento, 10.1016/s0210-5705(03)70383-5
  70. Covic Adrian, Goldsmith David J. A., Gusbeth-Tatomir Paul, Volovat Carmen, Dimitriu Alexandru G., Cristogel Florin, Bizo Aurel, Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion : MARS dialysis in mushroom intoxications, 10.1034/j.1478-3231.23.s.3.9.x
  71. Faybik Peter, Hetz Hubert, Baker Amir, Bittermann Clemens, Berlakovich Gabriela, Werba Alois, Krenn Claus-Georg, Steltzer Heinz, Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning : Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning, 10.1034/j.1478-3231.23.s.3.8.x
  72. Rubik Jacek, Pietraszek-Jezierska Elżbieta, Kamiński Andrzej, Skarzynska Anna, Jóźwiak Sergiusz, Pawłowska Joanna, Drewniak Tomasz, Prokurat Sylwester, Grenda Ryszard, Kaliciński Piotr, Successful treatment of a child with fulminant liver failure and coma caused byAmanita phalloidesintoxication with albumin dialysis without liver transplantation, 10.1111/j.1399-3046.2004.00170.x
  73. Wu BF, Hepatobiliary Pancreat Dis Int, 3, 152 (2004)
  74. Hydzik P, Przegl Lek, 62, 475 (2005)
  75. Lionte C, Rom J Gastroenterol, 14, 267 (2005)
  76. Sein Anand J, Przegl Lek, 62, 480 (2005)
  77. Sein Anand J, Przegl Lek, 64, 255 (2007)
  78. Wisniewski M, Clin Toxicol, 46, 402 (2008)
  79. Wisniewski M, Clin Toxicol, 46, 408 (2008)
  80. Kantola Taru, Kantola Teemu, Koivusalo Anna-Maria, Höckerstedt Krister, Isoniemi Helena, Early Molecular Adsorbents Recirculating System Treatment ofAmanitaMushroom Poisoning, 10.1111/j.1744-9987.2009.00758.x
  81. Sorodoc Laurentiu, Lionte Catalina, Sorodoc Victorita, Petris Ovidiu, Jaba Irina, Is MARS system enough for A.phalloides-induced liver failure treatment?, 10.1177/0960327110363327
  82. Kramer Ludwig, Bauer Edith, Schenk Peter, Steininger Rudolf, Vigl Marion, Mallek Reinhold, Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus), 10.1007/bf03040456
  83. Sein Anand J, Przegl Lek, 63, 514 (2006)
  84. Choi Jong Young, Bae Si Hyun, Yoon Seung Kew, Cho Se Hyun, Yang Jin Mo, Han Joon Yeol, Ahn Byung Min, Chung Kyu Won, Sun Hee Sik, Kim Dong Goo, Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study, 10.1111/j.1478-3231.2005.01074.x
  85. Lee Kang-Hoe, Lee Margaret Kwee-Hiang, Sutedja Dede Selamat, Lim Seng-Gee, Outcome from molecular adsorbent recycling system (MARStm) liver dialysis following drug-induced liver failure, 10.1111/j.1478-3231.2005.01091.x
  86. Yang Wen Shin, Tan Han Khim, Lui Hock Foong, Chow Pierce K., Choong Hui Lin, Wong Kok Seng, Albumin Dialysis in Critically Ill Patients: Use Versus Omission of Intradialytic Heparin, 10.1111/j.1525-1594.2008.00560.x
  87. Doria Cataldo, Mandalá Lucio, Scott Victor L., Gruttadauria Salvatore, Marino Ignazio R., Fulminant Hepatic Failure Bridged to Liver Transplantation with a Molecular Adsorbent Recirculating System: A Single-Center Experience, 10.1007/s10620-006-3115-1
  88. Page M, Ann Fr Anesth Rean, 27, 242 (2008)
  89. Braun Claude, Birck Rainer, Singer Manfred V, Schnuelle Peter, van der Woude Fokko J, Löhr Matthias, Life-threatening intoxication with methylene bis(thiocyanate): clinical picture and pitfalls. A case report, 10.1186/1471-227x-6-5
  90. Fagugli R.M., Gentile G., Ferrara G., Brugnano R., Acute renal and hepatic failure associated with allopurinol treatment, 10.5414/cnp70523
  91. Chua H.C., Venketasubramanian N., Tjia H., Chan S.P., Elimination of phenytoin in toxic overdose, 10.1016/s0303-8467(99)00074-8
  92. Martin Ernst, Removal of Phenytoin by Hemodialysis in Uremic Patients, 10.1001/jama.1977.03280170044025
  93. Sen Sambit, Ratnaraj Neville, Davies Nathan A., Mookerjee Rajeshwar P., Cooper Christopher E., Patsalos Philip N., Williams Roger, Jalan Rajiv, Treatment of Phenytoin Toxicity by the Molecular Adsorbents Recirculating System (MARS), 10.1046/j.1528-1157.2003.31402.x
  94. De Schoenmakere Gert, De Waele Jan, Terryn Wim, Deweweire Mieke, Verstraete Alain, Hoste Eric, Rottey Sylvie, Lameire Norbert, Colardyn Francis, Phenytoin intoxication in critically ill patients, 10.1053/j.ajkd.2004.09.016
  95. Brodie M.J., Lamotrigine, 10.1016/0140-6736(92)91207-o
  96. Mecarelli Oriano, Pulitano Patrizia, Mingoia Marielisa, Ferretti Giancarlo, Rossi Massimo, Berloco Pasquale B., Muda Andrea Onetti, Acute Hepatitis Associated with Lamotrigine and Managed with the Molecular Adsorbents Recirculating System (MARS), 10.1111/j.1528-1167.2005.00269.x
  97. LEE CHING S., MARBURY THOMAS C., PERRIN JOHN H., FULLER THOMAS J., Hemodialysis of Theophylline in Uremic Patients, 10.1002/j.1552-4604.1979.tb01655.x
  98. Stange J., Ramlow W., Mitzner S., Schmidt R., Klinkmann H., Dialysis against a Recycled Albumin Solution Enables the Removal of Albumin-Bound Toxins, 10.1111/j.1525-1594.1993.tb00635.x
  99. Korsheed S., Selby N. M., Fluck R. J., Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS), 10.1093/ndt/gfl640
  100. Higgins R. M., Hearing S., Goldsmith D. J., Keevil B., Venning M. C., Ackrill P., Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?, 10.1136/pgmj.71.834.224
  101. Shepherd G., Treatment of poisoning caused by  -adrenergic and calcium-channel blockers, 10.2146/ajhp060041
  102. BLOEDOW D. C., PIEPHO R. W., NIES A. S., GAL J., Serum Binding of Diltiazem in Humans, 10.1002/j.1552-4604.1982.tb02163.x
  103. Pichon Nicolas, François Bruno, Clavel Marc, Vignon Philippe, Chevreuil Caroline, Michel Gaulier Jean, Letter to the Editor: Albumin Dialysis: A New Therapeutic Alternative for Severe Diltiazem Intoxication, 10.1080/15563650500516041
  104. Prokurat S, Grenda R, Lipowski D, Kalicinski P, Migdal M., Prokurat S, Grenda R, Lipowski D, Kalicinski P, Migdal M, MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium-copper acute intoxication: a paediatric case report, 10.1034/j.1600-0676.2002.00016.x
  105. Kreymann Bernhard, Seige Markus, Schweigart Ursula, Kopp Klaus-Friedrich, Classen Meinhard, Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins, 10.1016/s0168-8278(99)80322-5
Bibliographic reference Wittebole, Xavier ; Hantson, Philippe. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. In: Clinical Toxicology, Vol. 49, no. 9, p. 782-793 (2011)
Permanent URL http://hdl.handle.net/2078.1/105875